Dr. Lydia Kiger MD
Neurologist | Neurology
377 W SPRUCE AVE CLOVIS CA, 93611About
Dr. Lydia Kiger is a distinguished Neurologist in CLOVIS, CA. Dr. Kiger specializes in diagnosing, treating, and managing disorders of the brain and nervous system. With expertise in handling complex conditions like epilepsy, multiple sclerosis, and migraines, Dr. Kiger employs advanced techniques and personalized treatment plans to improve patient outcomes. As a neurologist, Dr. Kiger is committed to staying abreast of the latest developments in neurological research and therapies.
Provider Details
Dr. Lydia Kiger MD's Practice location
Dr. Lydia Kiger MD's reviews
Write ReviewRecommended Articles
- The Impact Parkinson's Disease Has on Driving
It may start with a tremor followed by muscle stiffness and a decrease range of movement but as Parkinson’s disease progresses so do its side effects. Aside from the well-known and more common symptoms of Parkinson’s disease, a positive diagnosis also means a whole slew of secondary symptoms...
- Are There Risks to a Spinal Stenosis Surgery?
Like any other surgical procedure, spinal stenosis surgery has its own risks and possible complications. However, if performed correctly by professional medical staff, the possibility of any complication after the surgery is low.The potential risks and possible complications following a spinal...
- Recently Approved Multiple Sclerosis Drug Shows Promise
Only 50 years ago, there was no way possible to treat multiple sclerosis. Then, in the mid-1970s, a team of researchers and doctors used chemotherapy for the first time to treat the neurological disease. Since that first treatment, more than 10 new drugs have been developed and approved. Some of...
- New Multiple Sclerosis Treatment, Ocrevus, Slows Down Disease Progression
In 2017, the United States Food and Drug Administration (USFDA) approved the drug – Ocrevus (ocrelizumab) – as a treatment for both relapsing and progressive forms of multiple sclerosis. ...
- Diabetes Drug May Help Prevent Parkinson's, Study Shows
Drugs used to treat type 2 diabetes, belonging to a class called glitazones (GTZs) may reduce the risk of Parkinson’s by as much as 28 percent, a study suggests. It was a large scale study done by analyzing more than 100 million prescriptions. ...
- Coping with a Parkinson’s Disease Diagnosis
If you take an early action on the disease, then you will be able to deal with the symptoms. Above all, education and support enable you to live and fight the challenges that lay ahead. In addition to that, having a professional counselor is critical in designing a treatment plan for you. You not...